Skip to main content

Vitamin A and the Skin

  • Chapter
  • First Online:
Nutrition and Skin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abbott RA, Whittaker SJ, Morris SL, Russell-Jones R, Hung T, Bashir SJ, et al. Bexarotene therapy for mycosis fungoides and Sézary syndrome. Br J Dermatol. 2009;160:1299–307.

    Article  PubMed  CAS  Google Scholar 

  • Abdel Naser MB, Zouboulis CC. Retinoids in the management of non melanoma skin cancer. In: Jemec GBE, Kemény L, Mieh D, editors. Non-surgical treatment of keratinocyte skin cancer. Berlin/Heidelberg: Springer; 2010. p. 187–95.

    Chapter  Google Scholar 

  • Adams J, Kiss E, Arroyo AB, Bonrouhi M, Sun Q, Li Z, Gretz N, Schnitger A, Zouboulis CC, Wiesel M, Wagner J, Nelson PJ, Gröne HJ. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol. 2005;167:285–98.

    PubMed  Google Scholar 

  • Avis I, Mathias A, Unsworth EJ, Miller MJ, Cuttitta F, Mulshine JL, et al. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ. 1995;6:485–92.

    PubMed  CAS  Google Scholar 

  • Ayer DE, Lawrence QA, Eisenman RN. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell. 1995;80:767–76.

    Article  PubMed  CAS  Google Scholar 

  • Barth JH, MacDonald-Hull SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol. 1993;129:704–7.

    Article  PubMed  CAS  Google Scholar 

  • Benifla JL, Ville Y, Imbert MC, Frydman R, Thomas A, Pons JC. Fetal tissue dosages of retinoids: experimental study concerning a case of isotretinoin (Roaccutan) administration and pregnancy. Fetal Diagn Ther. 1995;10:189–91.

    Article  PubMed  CAS  Google Scholar 

  • Biesalski HK. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology. 1989;57:117–61.

    PubMed  Google Scholar 

  • Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol. 2005;4:41–7.

    PubMed  Google Scholar 

  • Bollag W, Ott F. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid. Dermatology. 1999;199:308–12.

    Article  PubMed  CAS  Google Scholar 

  • Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol. 2007;25:1974–8.

    Article  PubMed  CAS  Google Scholar 

  • Chen WC, Sass JO, Seltmann H, Nau H, Orfanos CE, Zouboulis CC. Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid. Arch Dermatol Res. 2000;292:612–20.

    PubMed  Google Scholar 

  • Chroni E, Monastirli A, Tsambaos D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf. 2010;33:25–34.

    Article  PubMed  CAS  Google Scholar 

  • Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a metaanalysis of five randomized trials. Br J Dermatol. 1998;139 Suppl 52:48–56.

    Article  PubMed  CAS  Google Scholar 

  • Del Rosso JQ. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. J Drugs Dermatol. 2007;6:616–22.

    PubMed  Google Scholar 

  • Downie MM, Sanders DA, Kealey T. Modelling the remission of individual acne lesions in vitro. Br J Dermatol. 2002;147:869–78.

    PubMed  Google Scholar 

  • Duvic M. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms. Clin Lymphoma. 2000;1 Suppl 1:S51–5.

    Article  PubMed  Google Scholar 

  • Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, et al. Bexarotene is effective and safe for treatment of refractory, advanced-stage cutaneous T-cell lymphoma: multinational phase II-m trial results. J Clin Oncol. 2001a;19:2456–71.

    PubMed  CAS  Google Scholar 

  • Duvic M, Martin AG, Kim Y, et al. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol. 2001b;137:581–93.

    PubMed  CAS  Google Scholar 

  • Enders SI, Enders IM. Isotretinoin and psychiatric iIInessin adolescents and young adults. Ann Pharmacother. 2003;37:1124–7.

    Article  PubMed  Google Scholar 

  • Estival JL, Dupin M, Kanitakis J, Combemale P. Capillary leak syndrome induced by acitretin. Br J Dermatol. 2004;150:150–2.

    Article  PubMed  CAS  Google Scholar 

  • Ethan-Quan, Wolverton. Ligand Pharmaceuticals. Targretin (bexarotene) capsules prescribing information. San Diego, CA. 2003.

    Article  PubMed  CAS  Google Scholar 

  • Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994;372:107–11.

    Article  PubMed  CAS  Google Scholar 

  • Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. Expert Rev Dermatol. 2007;2:693–706.

    Article  CAS  Google Scholar 

  • Gold JA, Schupack JL, Nemel MA. Ocular side effects of retinoids. Int J Dermatol. 1989;28:218–25.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol. 1989;21:144–5.

    Article  PubMed  CAS  Google Scholar 

  • Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1–37.

    Article  PubMed  Google Scholar 

  • Gupta AK, Goldfarb MT, Ellis CN, Voorhees JJ. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol. 1989;20:1088–93.

    Article  PubMed  CAS  Google Scholar 

  • Guy R, Ridden C, Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol. 1996;106:454–60.

    PubMed  Google Scholar 

  • Hanifi JM, Stevens V, Sheth P, et al. Novel treatment of severe chronic hand dermatitis with bexarotene gel. Br J Dermatol. 2004;150:545–53.

    Article  Google Scholar 

  • Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 1997;89:341–7.

    Article  PubMed  CAS  Google Scholar 

  • Haugen BR. Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab. 2009;23:793–800.

    Article  PubMed  CAS  Google Scholar 

  • Imam A, Hoyos B, Swenson C, Levi E, Chua R, Viriya E, et al. Retinoids as ligands and coactivators of protein kinase C alpha. FASEB J. 2001;15:28–30.

    PubMed  CAS  Google Scholar 

  • Jones DA. The potential immunomodulatory effects of topical retinoids. Dermatol Online J. 2005;11:3.

    PubMed  Google Scholar 

  • Kanekura T, Higashi Y, Kanzaki T. Inhibitory effects of 9-cis-retinoic acid and pyrrolidinedithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells. Cancer Lett. 2000;161:177–83.

    Article  PubMed  CAS  Google Scholar 

  • Karlsson T, Vahlquist A, Kedishvili N, Törmä H. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem Biophys Res Commun. 2003;303:273–8.

    Article  PubMed  CAS  Google Scholar 

  • King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107:583–90.

    PubMed  Google Scholar 

  • Korting HC, Braun-Falco O. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice. Drugs Exp Clin Res. 1989;15:447–51.

    PubMed  CAS  Google Scholar 

  • Kovach BT, Murphy G, Otley CC, Shumack S, Ulrich C, Stasko T. Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey. Transplant Proc. 2006;38:1366–8.

    Article  PubMed  CAS  Google Scholar 

  • Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318:1633–7.

    Article  PubMed  CAS  Google Scholar 

  • Lavker RM, Leyden JJ, Thorne EG. An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther. 1992;14:773–80.

    PubMed  CAS  Google Scholar 

  • Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol. 2006;20:773–6.

    PubMed  Google Scholar 

  • Lippman SM, Kesseier JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part 11). Cancer Treat Rep. 1987;21:493–515.

    Google Scholar 

  • Marazzi P, Boorman GC, Donald AE, Davies HD. Clinical evaluation of double strength isotrexin versus benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatol Treat. 2002;13:111–7.

    Article  CAS  Google Scholar 

  • Mills OH Jr, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol. 1978;58:555–7.

    PubMed  Google Scholar 

  • Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006;126:2178–89.

    Article  PubMed  CAS  Google Scholar 

  • Nguyen EH, Wolverton SE. Systemic retinoids. In: Wolverton SE, Wilkin JK, editors. Systemic drugs for skin diseases. Philadelphia: WB Saunders; 2000. p. 269–310.

    Google Scholar 

  • Olsen EA, Weed WW, Meyer CJ, Cobo LM. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis. J Am Acad Dermatol. 1989;21:681–6.

    Article  PubMed  CAS  Google Scholar 

  • Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196:140–7.

    Article  PubMed  CAS  Google Scholar 

  • Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen C. Current use and future potential role of retinoids in dermatology. Drugs. 1997;53:358–88.

    Article  PubMed  CAS  Google Scholar 

  • Otley CC, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg. 2006;32:562–8.

    Article  PubMed  CAS  Google Scholar 

  • Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol. 2005;125:673–84.

    Article  PubMed  CAS  Google Scholar 

  • Rollman O, Vahlquist A. Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin. J Invest Dermatol. 1986;86:384–9.

    Article  Google Scholar 

  • Rook AH, Jaworsky C, Nguyen T, Grossman RA, Wolfe JT, Witmer WK, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation. 1995;59:714–9.

    Article  PubMed  CAS  Google Scholar 

  • Ruzicka T, Larsen FG, Galewicz D, Horváth A, Coenraads PJ, Thestrup-Pedersen K, et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol. 2004;140:1453–9.

    Article  PubMed  CAS  Google Scholar 

  • Scheinfeld N, Bangalore S. Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. J Drugs Dermatol. 2006;5:467–8.

    PubMed  Google Scholar 

  • Shuttleworth D, Marks R, Griftin PJ, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med. 1988;68:717–25.

    PubMed  CAS  Google Scholar 

  • Smit JW, Stokkel MP, Pereira AM, Romijn JA, Visser TJ. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. J Clin Endocrinol Metab. 2007;92:2496–9.

    Article  PubMed  CAS  Google Scholar 

  • Stephensen CB, Rasooly R, Jiang X, Ceddia MA, Weaver CT, Chandraratna RA, et al. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol. 2002;168:4495–503.

    PubMed  CAS  Google Scholar 

  • Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, et al. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res. 2000;6:1563–73.

    PubMed  CAS  Google Scholar 

  • Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A. Tazarotene versus tazarotene plus clindamycin/ benzoyl peroxide in the treatment of acne vulgaris: a multicenter, doubleblind, randomized parallel-group trial. J Drugs Dermatol. 2006;5:256–61.

    PubMed  Google Scholar 

  • Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator- blind, randomized, controlled study. Skinmed. 2005;4:138–46.

    Article  PubMed  Google Scholar 

  • Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791–9.

    Article  PubMed  Google Scholar 

  • Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol. 2007;21:747–53.

    Article  PubMed  CAS  Google Scholar 

  • Thomas X, Anglaret B, Thiebaut A, Belhabri A, Treille-Ritouet D, Fiere D, Archimbaud E. Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy. Ann Hematol. 1997;75:195–200.

    PubMed  Google Scholar 

  • Tsukada M, Schröder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, Orfanos CE, Zouboulis CC. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol. 2000;115:321–7.

    PubMed  Google Scholar 

  • Tsukada M, Schröder M, Seltmann H, Orfanos CE, Zouboulis CC. High albumin levels restrict the kinetics of 13-cis retinoic acid uptake and intracellular isomerization to all-trans retinoic acid and inhibit its anti-proliferative effect on SZ95 sebocytes. J Invest Dermatol. 2002;119: 182–5.

    Article  PubMed  CAS  Google Scholar 

  • Vane FM, Bugge CJL, Rodriguez LC, Rosenberger M, Doran TI. Human biliary metabolites of isotretinoin: identification, quantification, synthesis, and biological activity. Xenobiotica. 1990;20:193–207.

    Article  PubMed  CAS  Google Scholar 

  • Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B. Treatment of AIDS related cutaneous Kaposi’s sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. J Acquir Immune Defic Syndr. 1999;22:235–46.

    Article  PubMed  CAS  Google Scholar 

  • Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002;69:4–11.

    PubMed  Google Scholar 

  • Wiegand UW, Chou RC. Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol. 1998;39:S25–33.

    Article  PubMed  CAS  Google Scholar 

  • Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142:1016–22.

    Article  PubMed  CAS  Google Scholar 

  • Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatol Treat. 2004;15:372–8.

    Article  CAS  Google Scholar 

  • Zouboulis CC, Korge BP, Mischke D, Orfanos CE. Altered proliferation, synthetic activity, and differentiation of cultured human sebocytes in the absence of vitamin A and their modulation by synthetic retinoids. J Invest Dermatol. 1993;101:628–33.

    PubMed  Google Scholar 

  • Zouboulis CC, Orfanos CE. Retinoids. In: Millikan LE, editor. Drug therapy in dermatology. New York/Basel: Marcel Dekker; 2000. p. 171–233.

    Google Scholar 

  • Zouboulis CC, Chen WC, Sass JO, Seltmann H, Nau H, Orfanos CE. Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid. Arch Dermatol Res. 2000;292:612–20.

    PubMed  Google Scholar 

  • Zouboulis CC. Retinoids – which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol. 2001;14:303–15.

    PubMed  CAS  Google Scholar 

  • Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206:37–53.

    Article  PubMed  CAS  Google Scholar 

  • Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006a;126:2154–6.

    Article  PubMed  CAS  Google Scholar 

  • Zouboulis CC. The truth behind this undeniable efficacy – recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology. 2006b;212:99–100.

    Article  PubMed  Google Scholar 

  • Zouboulis CC, Rabe T. Hormonal antiandrogens in acne treatment. J Dtsch Dermatol Ges. 2010;8 Suppl 1:S60–74.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christos C. Zouboulis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Elewa, R.M., Zouboulis, C.C. (2011). Vitamin A and the Skin. In: Pappas, A. (eds) Nutrition and Skin. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7967-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7967-4_2

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7966-7

  • Online ISBN: 978-1-4419-7967-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics